Massachusetts bill H5550 restricts the use of DEHP in intravenous solutions and tubing.

Massachusetts bill H5550 amends the General Laws to restrict the use of Di(2-ethylhexyl)phthalate (DEHP) in intravenous solutions and tubing. Specifically, it prohibits the manufacture, sale, or distribution of intravenous solution containers and tubing products containing intentionally added DEHP, except where it serves a functional or technical purpose. The bill also bans replacing DEHP with other ortho-phthalates in new or revised products. The provisions take effect on January 1, 2030, and January 1, 2035, respectively.

Massachusetts bill H5550 restricts the use of DEHP in intravenous solutions and tubing.

Massachusetts bill H5550 amends the General Laws to restrict the use of Di(2-ethylhexyl)phthalate (DEHP) in intravenous solutions and tubing. Specifically, it prohibits the manufacture, sale, or distribution of intravenous solution containers and tubing products containing intentionally added DEHP, except where it serves a functional or technical purpose. The bill also bans replacing DEHP with other ortho-phthalates in new or revised products. The provisions take effect on January 1, 2030, and January 1, 2035, respectively.